Publications by authors named "Ram Doolman"

Claim this Profile
H
Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.
Yaniv Lustig, Noam Barda, Yael Weiss-Ottolenghi, Victoria Indenbaum, Ili Margalit, Ram Doolman

Vaccine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022- and 2023.
Yaniv Lustig, Michal Canetti, Victoria Indenbaum, Yovel Peretz, Yael Weiss-Ottolenghi, Ram Doolman

Emerg Infect Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up" [Clin Microbiol Infect] 29 (7) (2023) 918-923.
Noam Barda, Yaniv Lustig, Victoria Indenbaum, Daniel Zibly, Gili Joseph, Ram Doolman

Clin Microbiol Infect· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines.
Tal Gonen, Noam Barda, Keren Asraf, Gili Joseph, Yael Weiss-Ottolenghi, Ram Doolman

JAMA Netw Open· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of Omicron BA.1-adapted BNT162b2 vaccines: randomized trial, 3-month follow-up.
Noam Barda, Yaniv Lustig, Victoria Indenbaum, Daniel Zibly, Gili Joseph, Ram Doolman

Clin Microbiol Infect· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel (ICoFS): a prospective cohort study.
Gili Regev-Yochay, Yaniv Lustig, Gili Joseph, Mayan Gilboa, Noam Barda, Ram Doolman

Lancet Microbe· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated With Protection From SARS-CoV-2 Omicron Variant Infection and Disease Among Vaccinated Health Care Workers in Israel.
Mayan Gilboa, Tal Gonen, Noam Barda, Shelly Cohn, Victoria Indenbaum, Ram Doolman

JAMA Netw Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Association Between Prebooster Vaccination Antibody Levels and the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Noam Barda, Michal Canetti, Mayan Gilboa, Keren Asraf, Victoria Indenboim, Ram Doolman

Clin Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
Omri Cohen, Nitsan Landau, Einat Avisahai, Tami Brutman-Barazani, Ivan Budnik, Ram Doolman

Acta Haematol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Ram Doolman

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL.
Ohad Benjamini, Rotem Gershon, Erez Bar-Haim, Yaniv Lustig, Hila Cohen, Ram Doolman

Eur J Haematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral Response to the Fourth BNT162b2 Vaccination and Link Between the Fourth Dose, Omicron Infection, and Disease Severity in Renal Transplant Recipients.
Tammy Hod, Aharon Ben-David, Eytan Mor, Liraz Olmer, Rebecca Halperin, Ram Doolman

Transplantation· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients.
Yana Davidov, Victoria Indenbaum, Michal Mandelboim, Keren Asraf, Tal Gonen, Ram Doolman

Viruses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Keren Asraf, Ram Doolman

N Engl J Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.
Michal Canetti, Noam Barda, Mayan Gilboa, Victoria Indenbaum, Michal Mandelboim, Ram Doolman

Nat Commun· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Immune Response Rate to the Fourth Boost of the BNT162b2 Vaccine against the Omicron Variants of Concern among Liver Transplant Recipients.
Yana Davidov, Victoria Indenbaum, Nofar Atari, Limor Kliker, Keren Tsaraf, Ram Doolman

Viruses· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maternal and Neonatal Immune Responses Following COVID-19 Infection and Vaccinations in Pregnancy.
Shlomi Toussia-Cohen, Omer Nir, Ravit Peretz-Machluf, Shiran Bookstein-Peretz, Omri Segal, Ram Doolman

Vaccines (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.
Mayan Gilboa, Gili Regev-Yochay, Michal Mandelboim, Victoria Indenbaum, Keren Asraf, Ram Doolman

JAMA Netw Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing immunogenicity and efficacy of two different mRNA-based COVID-19 vaccines as a fourth dose; six-month follow-up, Israel, 27 December 2021 to 24 July 2022.
Noam Barda, Michal Canetti, Mayan Gilboa, Victoria Indenboim, Keren Asraf, Ram Doolman

Euro Surveill· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Adverse Events and Immune Response Following Second and Third COVID-19 Vaccination in Pregnancy.
Shlomi Toussia-Cohen, Yoav Yinon, Ravit Peretz-Machluf, Omri Segal, Noam Regev, Ram Doolman

J Clin Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine.
Itzchak Levy, Einav Gal Levin, Liraz Olmer, Gili Regev-Yochay, Nancy Agmon-Levin, Ram Doolman

Vaccines (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
Yaniv Lustig, Tal Gonen, Lilac Meltzer, Mayan Gilboa, Victoria Indenbaum, Ram Doolman

Nat Immunol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron.
Gili Regev-Yochay, Tal Gonen, Mayan Gilboa, Michal Mandelboim, Victoria Indenbaum, Ram Doolman

N Engl J Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19-A Prospective Pilot Study.
Reut Kassif Lerner, Michal Stein Yeshurun, Rina Hemi, Nahid Zada, Keren Asraf, Ram Doolman

J Pers Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-155: A Potential Biomarker for Predicting Mortality in COVID-19 Patients.
Reut Kassif-Lerner, Keren Zloto, Nadav Rubin, Keren Asraf, Ram Doolman

J Pers Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis